IR

Iyona Rajkomar

Managing Partner, Dawn Biopharma

Greater London, England

Investor
VC

Invests in

Stages:

Series A
Seed

Locations:

London

  • Min Investment:

    $10,000,000.00

  • Max Investment:

    $50,000,000.00

  • Target Investment:

    $25,000,000.00

Skills

Management Consulting
Pharmaceutical Industry
Equity Research
Due Diligence
Business Transformation
Business Planning
Market Analysis
Market Research

Education

Investments

Adcytherix

Seed

Total Funding: $32M

ADCendo

Series A

Total Funding: $110M

AgomAb Therapeutics

Series C

Total Funding: $200M

Amolyt Pharma

Series B

Total Funding: $290M

Antios Therapeutics

Series B

Total Funding: $200M

Abcuro

Series A

Total Funding: $42M

Work Experience

Dawn Biopharma

2023

  • Managing Partner

    2023

Pontifax Venture Capital

2019 - 2023

  • Partner

    2019 - 2023

Advent Life Sciences LLP

2015 - 2019

  • Principal

    2017 - 2019

  • Associate

    2015 - 2017

Inventages Venture Capital

2014 - 2015

  • Investment Manager

    2014 - 2015

PwC

2011 - 2014

  • Strategy Consultant, Pharmaceuticals and Lifesciences

    2011 - 2014

    Areas of expertise - Strategic options development and analysis; - Business analysis and planning; - Strategic business development; - Commercial due diligence; - Market research, analysis and forecasting; - Project and programme management.

Bryan Garnier & Co

2009 - 2010

  • Equity Research Analyst

    2009 - 2010

    European pharma

UBS

2007 - 2009

  • Equity Research Analyst

    2007 - 2009

    Large cap European pharmaceuticals

St Georges Healthcare NHS Trust

2006 - 2007

  • Medical Doctor

    2006 - 2007